-
How Do Drugs Get Approved (and Fast-Tracked) by the FDA?
Read time: 5 minutes.
This is Part 3 in our series on how drugs get approved to treat lung cancer.
IN THE SPOTLIGHT
-
How We Define Success for a Clinical Trial
Read time: 6 minutes. This is Part 2 of 3 in our series on how drugs get approved to treat lung cancer. Make sure to read Part 1 on the phases of clinical trials and why they are... -
Understanding Clinical Trials: Why Are They Important for Drug Development?
Read time: 3 minutes. This is Part 1 in a 3-part series explaining how new drugs and treatments get approved to treat lung cancer. Parts 2 and 3 will be published in the coming... -
Countdown to ILCSC24: Bringing the World’s Experts Right to Your Living Room
Read time: 3 minutes. One of LUNGevity’s two flagship survivorship events, the International Lung Cancer Survivorship Conference (ILCSC), is being held virtually September 20 – 21... -
New NCCN Guidelines for Patients
The National Comprehensive Cancer Network (NCCN) is an alliance of leading cancer centers across the United States working together to improve cancer care. NCCN develops evidence... -
How Can Patients and Researchers Design Clinical Trials Together?
Read time: 2 minutes. Traditionally, people associate getting involved in lung cancer research with enrolling in a clinical trial. But most don’t realize they can also partner with... -
SCLC Virtual Meetup
SCLC patients/survivors - Join us the 3rd Wednesday of every month to c onnect with others who share common experiences and build your community. Register in advance for this... -
Small Cell Lung Cancer 101
Join small cell lung cancer expert Lauren Byers, MD, as she covers the key things patients need to know about SCLC in 30 minutes. Dr. Byers is a professor in the Department of... -
Researcher Aims to Bring 360-Degree Care to Young Adults Living with Lung Cancer
Young adults (less than 50 years of age) are being diagnosed with lung cancer at increasing rates. They tend to be women of Hispanic or Asian descent and are typically diagnosed... -
New Treatment Approved for Patients with Extensive Stage SCLC
On May 16, 2024, the US Food and Drug Administration (FDA) announced the accelerated approval of tarlatamab-dlle (Imdelltra®) to treat patients with extensive-stage small cell lung...
How Nina’s Clinical Trial Led to a High-Five Celebration
How Nina’s Clinical Trial Led to a High-Five Celebration
Her doctor was excited, which made Nina excited. They high-fived and couldn’t believe the progress that had been made in just a few weeks. The clinical trial was already having positive effects. Before her clinical trial success, Nina went through the standard treatments for people with small-cell lung cancer (SCLC). She was diagnosed in early 2014, and the plan was to try different chemo and radiation therapies.But, after 14 months of treatment with side-effects, it became clear the standard…
Let Your Voice Be Heard!
Let Your Voice Be Heard!
We are collecting stories from patients, caregivers, friends, and family members! Tell us how lung cancer has affected your life. Email your story to us at support@lungevity.org. Thanks!
One Patient's SCLC Journey
One Patient's SCLC Journey
Learn about small cell lung cancer through the eyes of a patient and his oncologist. Dr. Christine Lovly, internationally recognized medical oncologist, and Jeff Lackey, an SCLC survivor, discuss their journey, the importance of lung cancer screening, and key considerations when someone is newly diagnosed.
This session is moderated by Amy Moore, PhD, LUNGevity's Vice President of Global Engagement and Patient Partnerships. Christine M. Lovly, MD, PhD, is Associate Professor of Medicine…